Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allegion PLC stock logo
ALLE
Allegion
$143.80
+0.3%
$139.23
$113.27
$156.10
$12.34B1.02875,988 shs699,884 shs
Hinge Health Inc. stock logo
HNGE
Hinge Health
$46.36
+3.1%
$0.00
$33.42
$48.85
$3.51BN/A727,866 shs1.30 million shs
Icon Plc stock logo
ICLR
Icon
$144.56
-1.5%
$139.13
$125.10
$347.72
$11.85B1.151.11 million shs1.21 million shs
Stantec Inc. stock logo
STN
Stantec
$109.63
+1.2%
$99.50
$73.18
$109.67
$12.35B1.03148,600 shs204,758 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allegion PLC stock logo
ALLE
Allegion
+0.17%+4.54%+0.74%+12.06%+25.39%
Hinge Health Inc. stock logo
HNGE
Hinge Health
+3.32%+10.49%+4,635,999,900.00%+4,635,999,900.00%+4,635,999,900.00%
Icon Plc stock logo
ICLR
Icon
-1.49%-1.31%+10.49%-19.27%-53.81%
Stantec Inc. stock logo
STN
Stantec
+1.25%+4.22%+5.41%+33.63%+31.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allegion PLC stock logo
ALLE
Allegion
4.0218 of 5 stars
1.03.04.24.12.01.71.9
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/AN/AN/AN/A
Icon Plc stock logo
ICLR
Icon
4.3864 of 5 stars
4.33.00.00.02.13.32.5
Stantec Inc. stock logo
STN
Stantec
3.2159 of 5 stars
0.04.03.30.02.91.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allegion PLC stock logo
ALLE
Allegion
2.00
Hold$145.331.07% Upside
Hinge Health Inc. stock logo
HNGE
Hinge Health
3.00
Buy$46.00-0.78% Downside
Icon Plc stock logo
ICLR
Icon
2.60
Moderate Buy$213.0847.40% Upside
Stantec Inc. stock logo
STN
Stantec
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

Latest HNGE, STN, ALLE, and ICLR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Allegion PLC stock logo
ALLE
Allegion
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$170.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$48.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$48.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$45.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$45.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$41.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$46.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$50.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$42.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$47.00
(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allegion PLC stock logo
ALLE
Allegion
$3.77B3.28$8.98 per share16.01$17.26 per share8.33
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/AN/A
Icon Plc stock logo
ICLR
Icon
$8.28B1.41$19.75 per share7.32$117.92 per share1.23
Stantec Inc. stock logo
STN
Stantec
$5.47B2.28$5.33 per share20.57$18.84 per share5.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allegion PLC stock logo
ALLE
Allegion
$597.50M$7.1220.2018.044.0416.28%44.82%14.55%7/23/2025 (Estimated)
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/A0.00N/AN/AN/AN/AN/A
Icon Plc stock logo
ICLR
Icon
$791.47M$9.1815.759.451.809.25%11.46%6.49%7/23/2025 (Estimated)
Stantec Inc. stock logo
STN
Stantec
$263.82M$2.4245.3031.78N/A5.01%18.22%7.61%8/6/2025 (Estimated)

Latest HNGE, STN, ALLE, and ICLR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Allegion PLC stock logo
ALLE
Allegion
$1.99N/AN/AN/A$999.10 millionN/A
7/23/2025Q2 2025
Icon Plc stock logo
ICLR
Icon
$3.18N/AN/AN/A$1.98 billionN/A
5/14/2025Q1 2025
Stantec Inc. stock logo
STN
Stantec
$0.79$0.81+$0.02$0.61$1.54 billion$1.08 billion
4/30/2025Q1 2025
Icon Plc stock logo
ICLR
Icon
$3.17$3.19+$0.02$1.90$2.03 billion$2.00 billion
4/24/2025Q1 2025
Allegion PLC stock logo
ALLE
Allegion
$1.68$1.86+$0.18$1.71$918.53 million$941.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allegion PLC stock logo
ALLE
Allegion
$2.041.42%N/A28.65%11 Years
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/A
Icon Plc stock logo
ICLR
Icon
N/AN/AN/AN/AN/A
Stantec Inc. stock logo
STN
Stantec
$0.620.57%N/A25.62%13 Years

Latest HNGE, STN, ALLE, and ICLR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2025
Stantec Inc. stock logo
STN
Stantec
quarterly$0.16120.6%6/30/20256/30/20257/15/2025
4/10/2025
Allegion PLC stock logo
ALLE
Allegion
quarterly$0.511.67%6/13/20256/13/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allegion PLC stock logo
ALLE
Allegion
1.23
2.17
1.51
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/A
Icon Plc stock logo
ICLR
Icon
0.36
1.27
1.27
Stantec Inc. stock logo
STN
Stantec
0.41
1.38
1.38

Institutional Ownership

CompanyInstitutional Ownership
Allegion PLC stock logo
ALLE
Allegion
92.21%
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
Icon Plc stock logo
ICLR
Icon
95.61%
Stantec Inc. stock logo
STN
Stantec
63.86%

Insider Ownership

CompanyInsider Ownership
Allegion PLC stock logo
ALLE
Allegion
0.23%
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
Icon Plc stock logo
ICLR
Icon
44.00%
Stantec Inc. stock logo
STN
Stantec
0.46%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allegion PLC stock logo
ALLE
Allegion
14,40086.05 million85.85 millionOptionable
Hinge Health Inc. stock logo
HNGE
Hinge Health
1,51478.02 millionN/AN/A
Icon Plc stock logo
ICLR
Icon
41,90080.76 million45.22 millionOptionable
Stantec Inc. stock logo
STN
Stantec
32,000114.07 million113.54 millionOptionable

Recent News About These Companies

Bull of the Day: Stantec (STN)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allegion stock logo

Allegion NYSE:ALLE

$143.80 +0.41 (+0.29%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$143.56 -0.25 (-0.17%)
As of 06/27/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other. It also provides services and software, which includes inspection, maintenance, and repair services for its automatic entrance solutions; and software as a service, including access control, IoT integration, and workforce management solutions, as well as aftermarket services, design and installation offerings, and locksmith services. The company sells its products and solutions to end-users in commercial, institutional, and residential facilities, including education, healthcare, government, hospitality, retail, commercial office, and single and multi-family residential markets under the CISA, Interflex, LCN, Schlage, SimonsVoss, and Von Duprin brands. It sells its products and solutions through distribution and retail channels, such as specialty distribution, e-commerce, and wholesalers, as well as through various retail channels comprising do-it-yourself home improvement centers, online and e-commerce platforms, and small specialty showroom outlets. Allegion plc was incorporated in 2013 and is headquartered in Dublin, Ireland.

Hinge Health stock logo

Hinge Health NYSE:HNGE

$46.36 +1.40 (+3.11%)
As of 06/27/2025 03:58 PM Eastern

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation. Members receive personalized and largely automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Our platform can improve pain and function and reduce the need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life. There is no shortage of new technologies in the healthcare industry, yet the cost of care continues to rise. In other industries, the launch of new technologies has generally improved end-user experiences and lowered costs. In healthcare, however, new technologies have not always been successful in lowering the cost of care or improving clinical outcomes. We believe there are two key reasons for healthcare’s idiosyncratic response to technology: • Automating most aspects of care is difficult because so many healthcare interventions involve unstructured physical tasks. • The current framework for healthcare reimbursement has specific pathways to pay for care, which means new technologies are constrained to deliver within this framework. At Hinge Health, we have taken these challenges head-on. To address the automation of care, we have weaved together AI-enabled capabilities - such as our AI-powered motion tracking technology, TrueMotion, our proprietary FDA-cleared wearable device, Enso, and our AI-supported care team - to deliver scalable and personalized MSK care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. We have done this while improving our high member satisfaction over time. To address healthcare reimbursement constraints, we developed novel billing methods for our innovative technology by both directly selling to employers while also partnering with health plans, pharmacy benefit managers (“PBMs”), third-party administrators (“TPAs”), and other ecosystem entities to efficiently provide our platform to clients and members. While the MSK market is massive, existing solutions have fallen short as they are often expensive, ineffective, inconvenient to access, and delivered in a one-to-one or few-to-one care setting. Effective MSK care should be engaging, easy to use, and accessible anytime, anywhere. We developed Hinge Health to be simple and accessible, complete, personalized, and scalable. • Simple and accessible: We provide members access to our platform at no direct cost to them and without a copay or deductible. Members can access our broad spectrum of MSK care through a single on-demand app, designed to provide an engaging, seamless, and convenient digital experience whenever and wherever the member chooses. Potential members can complete a simple intake form, download the app, and start exercises soon thereafter. During the year ended December 31, 2024, approximately 64% of members were onboarded on the same day they completed their intake form, and approximately 75% of members were onboarded within the first week. • Complete: Our platform offers a wide range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. We also offer non-addictive and non-invasive pain relief via electrostimulation through our proprietary FDA-cleared wearable device, Enso, that is seamlessly integrated into our platform. • Personalized: Our platform delivers smarter care through AI and machine learning. Our AI model is trained on a large, proprietary MSK data set, and our technology is continuously learning and improving as each new member enrolls and engages with our programs, which creates a positive feedback loop. As of March 31, 2025, we had treated over one million members and our programs had tracked over 74 million activity sessions and 32 million member-reported outcome logs. We focus on personalization to keep members moving: from customized care plans to real-time in-app exercise feedback based on the member’s input and our proprietary motion tracking technology. • Scalable: Our AI-powered motion tracking technology, TrueMotion, allows us to deliver scalable and largely automated care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. While most of our programs provide members with access to a dedicated care team, our technology automates most aspects of care delivery while allowing our members to progress through their exercise therapy sessions on their own time. We have developed an efficient go-to-market model by working directly with our partners and clients. We seek to be the best solution on the market, the most validated solution on the market, and the easiest to buy. Our clients are primarily self-insured employers and include many of the nation’s leading enterprises across a broad range of industries and sizes. Within this segment, we also serve many public sector self-insured employers, such as state and local city governments and labor unions. In most instances, we partner with clients’ health plans, TPAs, PBMs, or other ecosystem entities to reduce the friction of contracting, procurement, security and IT reviews, onboarding, and billing. We are also in the early stages of expanding to serve health plans’ fully-insured and Medicare Advantage populations and federal insurance plans. As of December 31, 2024, we had approximately 20 million contracted lives across more than 2,250 clients. We had active client agreements with 49% of the Fortune 100 companies and 42% of the Fortune 500 companies, as of December 31, 2024. Despite this progress, our current contracted lives only represent 5% of our total addressable market. We believe that we grow efficiently because of our scalable, repeatable go-to-market model. We sell through our direct sales force and our partners. Once we contract with a client, we are most often the sole digital MSK care provider offered to their contracted lives. Our average contract term is three years. For the term of each contract, we are able to enroll, engage, and re-engage the client’s eligible lives, driving a recurring, repeatable revenue model, which is demonstrated in our net dollar retention of 117% as of December 31, 2024. Our 12-month client retention rate was 98% as of December 31, 2024. Additionally, we have a high level of client satisfaction, as shown by our client net promoter score (“NPS”) of 87 as of October 31, 2024. We also invested early in building our partner network. As of March 31, 2025, we had over 50 partners. Our partners include the five largest national health plans by self-insured lives, and the top three PBMs by market share. As of that date, we had retained 100% of our partners that we chose to work with since inception, excluding partners who were acquired. We have experienced significant growth since our inception, with a recurring revenue business model. As of December 31, 2024, we had over 532,000 members and more than 2,250 clients, compared to approximately 371,000 members and approximately 1,650 clients as of December 31, 2023. Our principal executive offices are located in San Francisco, California.

Icon stock logo

Icon NASDAQ:ICLR

$144.56 -2.19 (-1.49%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$144.55 -0.01 (-0.01%)
As of 06/27/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Stantec stock logo

Stantec NYSE:STN

$109.63 +1.33 (+1.23%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$109.63 +0.00 (+0.00%)
As of 06/27/2025 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stantec Inc. provides professional services in the areas of infrastructure and facilities to the public and private sectors in Canada, the United States, and internationally. It offers evaluation, planning, and designing infrastructure solutions; solutions for sustainable water resources, planning, management, and infrastructure; environmental services; integrated architecture, engineering, interior design, and planning solutions for buildings; and energy and resources solutions. The company also provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. In addition, it offers planning and design services to clients in residential, logistics, retail, infrastructure, energy, higher education, and urban regeneration sectors; architectural and interior design, and planning services in the science and technology, commercial workplace, higher education, residential, and hospitality markets. Further, the company provides transportation advisory, transport engineering, and technical design; project delivery consultancy services for mining, resources, and industrial infrastructure projects; paleontological and archaeological services for the rail, transportation, water, and power and energy sectors; and environmental and cultural resource compliance services. Additionally, it offers consulting services in sustainable building design, energy infrastructure upgrades, sustainable district heating network, and e-mobility; and planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation services. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.